Primary Biliary Cirrhosis Drug Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
SUMMARY
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Primary Biliary Cirrhosis Drug market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Primary Biliary Cirrhosis Drug market segmented into
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Primary Biliary Cirrhosis Drug market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Primary Biliary Cirrhosis Drug market segmented into
- Budesonide
- FFP-104
- GSK-2330672
- MBX-8025
- NGM-282
- Others
- Clinic
- Hospital
- Others
- North America [U.S., Canada, Mexico]
- Europe [Germany, UK, France, Italy, Rest of Europe]
- Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
- South America [Brazil, Argentina, Rest of Latin America]
- Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
- AlbireoPharma
- CymaBay Therapeutics, Inc.
- Dr. Falk Pharma GmbH
- Enanta Pharmaceuticals, Inc.
- GlaxoSmithKline Plc
- Intercept Pharmaceuticals, Inc.
- Johnson & Johnson
- MediGene AG
- NGM Biopharmaceuticals, Inc.
- Virobay Inc.
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL PRIMARY BILIARY CIRRHOSIS DRUG INDUSTRY
2.1 Summary about Primary Biliary Cirrhosis Drug Industry
2.2 Primary Biliary Cirrhosis Drug Market Trends
2.2.1 Primary Biliary Cirrhosis Drug Production & Consumption Trends
2.2.2 Primary Biliary Cirrhosis Drug Demand Structure Trends
2.3 Primary Biliary Cirrhosis Drug Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Budesonide
4.2.2 FFP-104
4.2.3 GSK-2330672
4.2.4 MBX-8025
4.2.5 NGM-282
4.2.6 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Clinic
4.3.2 Hospital
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Budesonide
5.2.2 FFP-104
5.2.3 GSK-2330672
5.2.4 MBX-8025
5.2.5 NGM-282
5.2.6 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Clinic
5.3.2 Hospital
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Budesonide
6.2.2 FFP-104
6.2.3 GSK-2330672
6.2.4 MBX-8025
6.2.5 NGM-282
6.2.6 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Clinic
6.3.2 Hospital
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Budesonide
7.2.2 FFP-104
7.2.3 GSK-2330672
7.2.4 MBX-8025
7.2.5 NGM-282
7.2.6 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Clinic
7.3.2 Hospital
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Budesonide
8.2.2 FFP-104
8.2.3 GSK-2330672
8.2.4 MBX-8025
8.2.5 NGM-282
8.2.6 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Clinic
8.3.2 Hospital
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Budesonide
9.2.2 FFP-104
9.2.3 GSK-2330672
9.2.4 MBX-8025
9.2.5 NGM-282
9.2.6 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Clinic
9.3.2 Hospital
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 AlbireoPharma
10.1.2 CymaBay Therapeutics, Inc.
10.1.3 Dr. Falk Pharma GmbH
10.1.4 Enanta Pharmaceuticals, Inc.
10.1.5 GlaxoSmithKline Plc
10.1.6 Intercept Pharmaceuticals, Inc.
10.1.7 Johnson & Johnson
10.1.8 MediGene AG
10.1.9 NGM Biopharmaceuticals, Inc.
10.1.10 Virobay Inc.
10.2 Primary Biliary Cirrhosis Drug Sales Date of Major Players (2017-2020e)
10.2.1 AlbireoPharma
10.2.2 CymaBay Therapeutics, Inc.
10.2.3 Dr. Falk Pharma GmbH
10.2.4 Enanta Pharmaceuticals, Inc.
10.2.5 GlaxoSmithKline Plc
10.2.6 Intercept Pharmaceuticals, Inc.
10.2.7 Johnson & Johnson
10.2.8 MediGene AG
10.2.9 NGM Biopharmaceuticals, Inc.
10.2.10 Virobay Inc.
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL PRIMARY BILIARY CIRRHOSIS DRUG INDUSTRY
2.1 Summary about Primary Biliary Cirrhosis Drug Industry
2.2 Primary Biliary Cirrhosis Drug Market Trends
2.2.1 Primary Biliary Cirrhosis Drug Production & Consumption Trends
2.2.2 Primary Biliary Cirrhosis Drug Demand Structure Trends
2.3 Primary Biliary Cirrhosis Drug Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Budesonide
4.2.2 FFP-104
4.2.3 GSK-2330672
4.2.4 MBX-8025
4.2.5 NGM-282
4.2.6 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Clinic
4.3.2 Hospital
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Budesonide
5.2.2 FFP-104
5.2.3 GSK-2330672
5.2.4 MBX-8025
5.2.5 NGM-282
5.2.6 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Clinic
5.3.2 Hospital
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Budesonide
6.2.2 FFP-104
6.2.3 GSK-2330672
6.2.4 MBX-8025
6.2.5 NGM-282
6.2.6 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Clinic
6.3.2 Hospital
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Budesonide
7.2.2 FFP-104
7.2.3 GSK-2330672
7.2.4 MBX-8025
7.2.5 NGM-282
7.2.6 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Clinic
7.3.2 Hospital
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Budesonide
8.2.2 FFP-104
8.2.3 GSK-2330672
8.2.4 MBX-8025
8.2.5 NGM-282
8.2.6 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Clinic
8.3.2 Hospital
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Budesonide
9.2.2 FFP-104
9.2.3 GSK-2330672
9.2.4 MBX-8025
9.2.5 NGM-282
9.2.6 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Clinic
9.3.2 Hospital
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 AlbireoPharma
10.1.2 CymaBay Therapeutics, Inc.
10.1.3 Dr. Falk Pharma GmbH
10.1.4 Enanta Pharmaceuticals, Inc.
10.1.5 GlaxoSmithKline Plc
10.1.6 Intercept Pharmaceuticals, Inc.
10.1.7 Johnson & Johnson
10.1.8 MediGene AG
10.1.9 NGM Biopharmaceuticals, Inc.
10.1.10 Virobay Inc.
10.2 Primary Biliary Cirrhosis Drug Sales Date of Major Players (2017-2020e)
10.2.1 AlbireoPharma
10.2.2 CymaBay Therapeutics, Inc.
10.2.3 Dr. Falk Pharma GmbH
10.2.4 Enanta Pharmaceuticals, Inc.
10.2.5 GlaxoSmithKline Plc
10.2.6 Intercept Pharmaceuticals, Inc.
10.2.7 Johnson & Johnson
10.2.8 MediGene AG
10.2.9 NGM Biopharmaceuticals, Inc.
10.2.10 Virobay Inc.
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
LIST OF TABLES
Table Primary Biliary Cirrhosis Drug Product Type Overview
Table Primary Biliary Cirrhosis Drug Product Type Market Share List
Table Primary Biliary Cirrhosis Drug Product Type of Major Players
Table Brief Introduction of AlbireoPharma
Table Brief Introduction of CymaBay Therapeutics, Inc.
Table Brief Introduction of Dr. Falk Pharma GmbH
Table Brief Introduction of Enanta Pharmaceuticals, Inc.
Table Brief Introduction of GlaxoSmithKline Plc
Table Brief Introduction of Intercept Pharmaceuticals, Inc.
Table Brief Introduction of Johnson & Johnson
Table Brief Introduction of MediGene AG
Table Brief Introduction of NGM Biopharmaceuticals, Inc.
Table Brief Introduction of Virobay Inc.
Table Products & Services of AlbireoPharma
Table Products & Services of CymaBay Therapeutics, Inc.
Table Products & Services of Dr. Falk Pharma GmbH
Table Products & Services of Enanta Pharmaceuticals, Inc.
Table Products & Services of GlaxoSmithKline Plc
Table Products & Services of Intercept Pharmaceuticals, Inc.
Table Products & Services of Johnson & Johnson
Table Products & Services of MediGene AG
Table Products & Services of NGM Biopharmaceuticals, Inc.
Table Products & Services of Virobay Inc.
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Primary Biliary Cirrhosis Drug Market Forecast (Million USD) by Region 2021f-2026f
Table Global Primary Biliary Cirrhosis Drug Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Primary Biliary Cirrhosis Drug Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Primary Biliary Cirrhosis Drug Market Forecast (Million USD) Share by Demand 2021f-2026f
Table Primary Biliary Cirrhosis Drug Product Type Overview
Table Primary Biliary Cirrhosis Drug Product Type Market Share List
Table Primary Biliary Cirrhosis Drug Product Type of Major Players
Table Brief Introduction of AlbireoPharma
Table Brief Introduction of CymaBay Therapeutics, Inc.
Table Brief Introduction of Dr. Falk Pharma GmbH
Table Brief Introduction of Enanta Pharmaceuticals, Inc.
Table Brief Introduction of GlaxoSmithKline Plc
Table Brief Introduction of Intercept Pharmaceuticals, Inc.
Table Brief Introduction of Johnson & Johnson
Table Brief Introduction of MediGene AG
Table Brief Introduction of NGM Biopharmaceuticals, Inc.
Table Brief Introduction of Virobay Inc.
Table Products & Services of AlbireoPharma
Table Products & Services of CymaBay Therapeutics, Inc.
Table Products & Services of Dr. Falk Pharma GmbH
Table Products & Services of Enanta Pharmaceuticals, Inc.
Table Products & Services of GlaxoSmithKline Plc
Table Products & Services of Intercept Pharmaceuticals, Inc.
Table Products & Services of Johnson & Johnson
Table Products & Services of MediGene AG
Table Products & Services of NGM Biopharmaceuticals, Inc.
Table Products & Services of Virobay Inc.
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Primary Biliary Cirrhosis Drug Market Forecast (Million USD) by Region 2021f-2026f
Table Global Primary Biliary Cirrhosis Drug Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Primary Biliary Cirrhosis Drug Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Primary Biliary Cirrhosis Drug Market Forecast (Million USD) Share by Demand 2021f-2026f
LIST OF FIGURES
Figure Global Primary Biliary Cirrhosis Drug Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Primary Biliary Cirrhosis Drug Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Primary Biliary Cirrhosis Drug Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Primary Biliary Cirrhosis Drug Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Primary Biliary Cirrhosis Drug Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Primary Biliary Cirrhosis Drug Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Primary Biliary Cirrhosis Drug Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Budesonide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure FFP-104 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GSK-2330672 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure MBX-8025 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure NGM-282 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Budesonide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure FFP-104 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GSK-2330672 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure MBX-8025 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure NGM-282 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Budesonide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure FFP-104 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GSK-2330672 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure MBX-8025 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure NGM-282 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Budesonide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure FFP-104 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GSK-2330672 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure MBX-8025 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure NGM-282 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Budesonide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure FFP-104 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GSK-2330672 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure MBX-8025 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure NGM-282 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Budesonide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure FFP-104 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GSK-2330672 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure MBX-8025 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure NGM-282 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Primary Biliary Cirrhosis Drug Sales Revenue (Million USD) of AlbireoPharma 2017-2020e
Figure Primary Biliary Cirrhosis Drug Sales Revenue (Million USD) of CymaBay Therapeutics, Inc. 2017-2020e
Figure Primary Biliary Cirrhosis Drug Sales Revenue (Million USD) of Dr. Falk Pharma GmbH 2017-2020e
Figure Primary Biliary Cirrhosis Drug Sales Revenue (Million USD) of Enanta Pharmaceuticals, Inc. 2017-2020e
Figure Primary Biliary Cirrhosis Drug Sales Revenue (Million USD) of GlaxoSmithKline Plc 2017-2020e
Figure Primary Biliary Cirrhosis Drug Sales Revenue (Million USD) of Intercept Pharmaceuticals, Inc. 2017-2020e
Figure Primary Biliary Cirrhosis Drug Sales Revenue (Million USD) of Johnson & Johnson 2017-2020e
Figure Primary Biliary Cirrhosis Drug Sales Revenue (Million USD) of MediGene AG 2017-2020e
Figure Primary Biliary Cirrhosis Drug Sales Revenue (Million USD) of NGM Biopharmaceuticals, Inc. 2017-2020e
Figure Primary Biliary Cirrhosis Drug Sales Revenue (Million USD) of Virobay Inc. 2017-2020e
Figure Global Primary Biliary Cirrhosis Drug Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Primary Biliary Cirrhosis Drug Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Primary Biliary Cirrhosis Drug Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Primary Biliary Cirrhosis Drug Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Primary Biliary Cirrhosis Drug Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Primary Biliary Cirrhosis Drug Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Primary Biliary Cirrhosis Drug Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Budesonide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure FFP-104 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GSK-2330672 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure MBX-8025 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure NGM-282 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Budesonide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure FFP-104 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GSK-2330672 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure MBX-8025 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure NGM-282 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Budesonide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure FFP-104 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GSK-2330672 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure MBX-8025 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure NGM-282 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Budesonide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure FFP-104 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GSK-2330672 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure MBX-8025 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure NGM-282 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Budesonide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure FFP-104 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GSK-2330672 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure MBX-8025 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure NGM-282 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Budesonide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure FFP-104 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GSK-2330672 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure MBX-8025 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure NGM-282 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Primary Biliary Cirrhosis Drug Sales Revenue (Million USD) of AlbireoPharma 2017-2020e
Figure Primary Biliary Cirrhosis Drug Sales Revenue (Million USD) of CymaBay Therapeutics, Inc. 2017-2020e
Figure Primary Biliary Cirrhosis Drug Sales Revenue (Million USD) of Dr. Falk Pharma GmbH 2017-2020e
Figure Primary Biliary Cirrhosis Drug Sales Revenue (Million USD) of Enanta Pharmaceuticals, Inc. 2017-2020e
Figure Primary Biliary Cirrhosis Drug Sales Revenue (Million USD) of GlaxoSmithKline Plc 2017-2020e
Figure Primary Biliary Cirrhosis Drug Sales Revenue (Million USD) of Intercept Pharmaceuticals, Inc. 2017-2020e
Figure Primary Biliary Cirrhosis Drug Sales Revenue (Million USD) of Johnson & Johnson 2017-2020e
Figure Primary Biliary Cirrhosis Drug Sales Revenue (Million USD) of MediGene AG 2017-2020e
Figure Primary Biliary Cirrhosis Drug Sales Revenue (Million USD) of NGM Biopharmaceuticals, Inc. 2017-2020e
Figure Primary Biliary Cirrhosis Drug Sales Revenue (Million USD) of Virobay Inc. 2017-2020e
